Showing results (1661-1670 of 2,109) with videos related to

Sort By:
Pageof 211
Bioorganic & Medicinal Chemistry|November 11, 2009
Optimization of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine-5-ylidene)acetamide derivatives as arginine vasopressin V2 receptor agonists and discussion of their binding modesIssei Tsukamoto, Hiroyuki Koshio, Masaya Orita, et al.
DNA and Cell Biology|July 1, 1994
Evolutionary conservation of function among mammalian, avian, and viral homologs of the Bcl-2 oncoproteinS Takayama, D L Cazals-Hatem, S Kitada, et al.
Anticancer Research|May 27, 2026
Clinical Outcomes and Failure Patterns After Postoperative IMRT for Olfactory Neuroblastoma: Late Cervical Nodal RelapseAkari Nishida, Ryota Nakashima, Shinya Hiraoka, et al.
Respiratory Investigation|January 26, 2024
Amikacin liposome inhalation suspension for Mycobacterium avium complex pulmonary disease: A subgroup analysis of Japanese patients in the randomized, phase 3, CONVERT studyKozo Morimoto, Mizu Nonaka, Yoshitaka Yamazaki, et al.
Kidney International|February 29, 2020
Lipopolysaccharide induces filtrate leakage from renal tubular lumina into the interstitial space via a proximal tubular Toll-like receptor 4-dependent pathway and limits sensitivity to fluid therapy in miceDaisuke Nakano, Kento Kitada, Ningning Wan, et al.
Nutrients|October 24, 2017
The Effect of Piceatannol from Passion Fruit (Passiflora edulis) Seeds on Metabolic Health in HumansMunehiro Kitada, Yoshio Ogura, Hiroko Maruki-Uchida, et al.
Journal of Cellular Biochemistry|January 1, 1996
BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapyJ C Reed, T Miyashita, S Takayama, et al.
Oncotarget|August 2, 2013
Small molecule-induced mitochondrial disruption directs prostate cancer inhibition via UPR signalingElizabeth Rico-Bautista, Wenhong Zhu, Shinichi Kitada, et al.
FEBS Letters|September 29, 1986
Isolation and structure of the Streptococcus faecalis sex pheromone, cAM373M Mori, H Tanaka, Y Sakagami, et al.
Journal of Medicinal Chemistry|August 6, 2011
Design and characterization of a potent and selective dual ATP- and substrate-competitive subnanomolar bidentate c-Jun N-terminal kinase (JNK) inhibitorJohn L Stebbins, Surya K De, Petra Pavlickova, et al.
Pageof 211